Table 1 Patient characteristics
From: Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma
| Â | Conventional(n = 32) | NACT(n = 27) | p |
|---|---|---|---|
Age | 53.6 ± 9.8 | 58.7 ± 4.6 | NS |
FIGO stage | Â | Â | Â |
   IIIc | 14 (43.8%) | 11 (40.7%) | NS |
   IV | 18 (56.2%) | 16 (59.3%) | NS |
Grade | Â | Â | Â |
   II | 14 (43.8%) | 12 (44.4%) | NS |
   III | 18 (56.2%) | 15 (55.6%) | NS |
Histological type: | Â | Â | Â |
   Serous | 9 (28.1%) | 7 (25.9%) | NS |
   Mucinous | 13 (40.6%) | 10 (37%) | NS |
   Undifferentiated | 10 (31.3%) | 10 (37%) | NS |
Staging procedure | Â | Â | Â |
   Laparoscopy | 21 (65.6%) | 17 (62.9%) | NS |
   Laparotomy | 11 (34.4%) | 10 (37.1%) | NS |